Search Results - "Kito, Kenichi"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Preferable effects of pemafibrate on liver function and fibrosis in subjects with type 2 diabetes complicated with liver damage by Nomoto, Hiroshi, Kito, Kenichi, Iesaka, Hiroshi, Handa, Takahisa, Yanagiya, Shingo, Miya, Aika, Kameda, Hiraku, Cho, Kyu Yong, Takeuchi, Jun, Nagai, So, Sakuma, Ichiro, Nakamura, Akinobu, Atsumi, Tatsuya

    Published in Diabetology and metabolic syndrome (26-10-2023)
    “…Background Pemafibrate has been reported to ameliorate lipid profiles and liver dysfunction. However, which patients derive benefit from the hepatoprotective…”
    Get full text
    Journal Article
  3. 3
  4. 4

    843-P: Effects of Pemafibrate on Glucose Metabolism in Adults with Type 2 Diabetes and Hypertriglyceridemia—Subanalysis of the PARM-T2D Study by NOMOTO, HIROSHI, KITO, KENICHI, NAKAMURA, AKINOBU, KAMEDA, HIRAKU, OMORI, KAZUNO, YANAGIYA, SHINGO, IESAKA, HIROSHI, OE, YUKI, KAWATA, SHINICHIRO, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Background and Aims: Pemafibrate, a novel selective peroxisome proliferator-activated receptor modulator, has been demonstrated to have potent effects on…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Immunological Study of Late Cerebral Vasospasm in Subarachnoid Hemorrhage by SHIMIZU, Takashi, KITO, Kenichi, HOSHI, Taeko, YAMAZAKI, Naomi, TAKAHASHI, Kenji, TAKAHASHI, Makoto, YAMANE, Kanji, SIM, Chungwoong, KITAMURA, Koichi, SENDO, Shigeru

    Published in Neurologia medico-chirurgica (1982)
    “…Using immunological studies, it was investigated whether any vasoactive substances were produced in the subarachnoid space and whether these substances…”
    Get full text
    Journal Article